Calgene, Monsanto licensing deal

Calgene Inc. concluded years of discussions and a year of serious negotiations with Monsanto Co. by signing a broad technology cross-licensing agreement that Calgene hopes will provide a model for the rest of the ag-biotech industry.

CGNE Chairman and CEO Roger Salquist told BioCentury, "I don't want our sector of the industry to get into brutal patent wars." Salquist stated, as he has publicly in the past, that he would rather focus on commercialization than spend money on litigation.